Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
By Omar MohammedNAIROBI, June 23 (Reuters) - Seychelles said on Wednesday it is looking to diversify its economy beyond its mainstay of tourism into areas such as fisheries after visitor numbers were battered by restrictions to arrest the spread o...
Read more
(Sharecast News) - Hunting: JP Morgan upgrades overweight with a target price of 290p.
Read more* GSK consumer arm to be demerged in middle of 2022* Drugs business to get 8 bln stg dividend from consumer arm* Lower debt ratio, dividend to boost finances of drugs arm (Adds details on dividend, debt, Pfizer comment, updates shares)By Ludwig Bur...
Read more* GSK consumer arm to be demerged in middle of 2022* Drugs business to get 8 bln stg dividend from consumer arm* Lower debt ratio, dividend to boost finances of drugs arm (Adds CEO comment, detail, background)By Ludwig Burger and Pushkala AripakaJun...
Read more(Adds details, background)June 23 (Reuters) - New GSK, the pharmaceuticals business being separated from its consumer health operations, pledged to increase sales by more than 5% a year to 2026, the group said on Wednesday, as it published details...
Read moreJune 23 (Reuters) - Britain's GSK on Wednesday unveiled a detailed plan to spin off its consumer healthcare venture with Pfizer into a separate company by the middle of next year, as the pharmaceutical giant sharpens its focus on prescription med...
Read more(Sharecast News) - India's Health Ministry has upgraded a new variant of Covid-19 dubbed Delta plus to a "variant of concern".
Read more(Sharecast News) - AstraZeneca announced on Wednesday that 'Orpathys', or savolitinib, has been granted conditional approval in China to treat patients with non-small cell lung cancer (NSCLC), with MET exon 14 skipping alterations who have progressed following prior systemic therapy or were unable to receive chemotherapy.
Read moreBy Fabian CamberoSANTIAGO, June 22 (Reuters) - Chile is studying the possibility of issuing a third, booster dose of COVID-19 vaccines, its president said on Tuesday, as the country seeks to beat back the latest wave of infections amid questions a...
Read more
IN BRIEF: Hutchmed lung cancer treatment savolitinib approved in China
Read more(Corrects paragraphs 8 and 9 to clarify insight was based on blood analysis, not cases of reinfection)* Variants may cause few breakthrough infections in vaccinated* Researchers find no evidence of widespread virus escape* Past infection with B117/...
Read more* Variants may cause few breakthrough infections in vaccinated* Researchers find no evidence of widespread virus escape* Past infection with B117/Alpha confers broad protection (Recasts, adds details on Pfizer-BioNTech vaccine)By Ludwig Burger and ...
Read moreAstraZeneca's Koselugo gets EU regulatory approval to treat children
Read more(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that its Koselugo drug had been approved for use in children with neurofibromatosis type 1 and plexiform neurofibromas across the European Union.
Read moreBy Dania NadeemJune 21 (Reuters) - COVID-19 therapies made from a cocktail of two types of antibodies were effective against a wide range of variants of the coronavirus in a mice and hamster study, the Washington University School of Medicine in S...
Read more
Last checked at